274 related articles for article (PubMed ID: 17999793)
1. Sinus fluid penetration of oral clarithromycin and azithromycin in patients with acute rhinosinusitis.
Margaritis VK; Ismailos GS; Naxakis SS; Mastronikolis NS; Goumas PD
Am J Rhinol; 2007; 21(5):574-8. PubMed ID: 17999793
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of azithromycin in serum and sinus fluid after administration of extended-release and immediate-release formulations in patients with acute bacterial sinusitis.
Ehnhage A; Rautiainen M; Fang AF; Sanchez SP
Int J Antimicrob Agents; 2008 Jun; 31(6):561-6. PubMed ID: 18456465
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of azithromycin in plasma and sinus mucosal tissue following administration of extended-release or immediate-release formulations in adult patients with chronic rhinosinusitis.
Fang AF; Palmer JN; Chiu AG; Blumer JL; Crownover PH; Campbell MD; Damle BD
Int J Antimicrob Agents; 2009 Jul; 34(1):67-71. PubMed ID: 19307106
[TBL] [Abstract][Full Text] [Related]
4. In vitro transcorneal diffusion of the antimicrobial macrolides azithromycin and clarithromycin and the impact on microbial keratitis.
van Eyk AD; Seifart HI; Meyer D; van der Bijl P
Cornea; 2009 May; 28(4):441-6. PubMed ID: 19411964
[TBL] [Abstract][Full Text] [Related]
5. Corneal pharmacokinetics of topically applied azithromycin and clarithromycin.
Kuehne JJ; Yu AL; Holland GN; Ramaswamy A; Taban R; Mondino BJ; Yu F; Rayner SA; Giese MJ
Am J Ophthalmol; 2004 Oct; 138(4):547-53. PubMed ID: 15488779
[TBL] [Abstract][Full Text] [Related]
6. Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial.
Marple BF; Roberts CS; de Caprariis PJ; Reisman A
Clin Ther; 2007 Dec; 29(12):2690-8. PubMed ID: 18201585
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary disposition of erythromycin, azithromycin, and clarithromycin in foals.
Suarez-Mier G; Giguère S; Lee EA
J Vet Pharmacol Ther; 2007 Apr; 30(2):109-15. PubMed ID: 17348895
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
9. Penetration of azithromycin in experimental pleural empyema fluid.
Saroglou M; Ismailos G; Tryfon S; Liapakis I; Papalois A; Bouros D
Eur J Pharmacol; 2010 Jan; 626(2-3):271-5. PubMed ID: 19854169
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of clarithromycin and concentrations in body fluids and bronchoalveolar cells of foals.
Womble AY; Giguère S; Lee EA; Vickroy TW
Am J Vet Res; 2006 Oct; 67(10):1681-6. PubMed ID: 17014316
[TBL] [Abstract][Full Text] [Related]
11. The effect of treatment with moxifloxacin or azithromycin on acute bacterial rhinosinusitis in mice.
Luxameechanporn T; Blair C; Kirtsreesakul V; Thompson K; Naclerio RM
Int J Infect Dis; 2006 Sep; 10(5):401-6. PubMed ID: 16564192
[TBL] [Abstract][Full Text] [Related]
12. Double-blind, placebo-controlled study comparing the effect of azithromycin with clarithromycin on oropharyngeal and bowel microflora in volunteers.
Matute AJ; Schurink CA; Krijnen RM; Florijn A; Rozenberg-Arska M; Hoepelman IM
Eur J Clin Microbiol Infect Dis; 2002 Jun; 21(6):427-31. PubMed ID: 12111597
[TBL] [Abstract][Full Text] [Related]
13. Disposition of oral azithromycin in humans.
Luke DR; Foulds G
Clin Pharmacol Ther; 1997 Jun; 61(6):641-8. PubMed ID: 9209246
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of azithromycin after single- and multiple-doses in children.
Stevens RC; Reed MD; Shenep JL; Baker DK; Foulds G; Luke DR; Blumer JL; Rodman JH
Pharmacotherapy; 1997; 17(5):874-80. PubMed ID: 9324176
[TBL] [Abstract][Full Text] [Related]
15. The newer macrolides. Azithromycin and clarithromycin.
Zuckerman JM; Kaye KM
Infect Dis Clin North Am; 1995 Sep; 9(3):731-45. PubMed ID: 7490441
[TBL] [Abstract][Full Text] [Related]
16. Azithromycin iv pharmacodynamic parameters predicting Streptococcus pneumoniae killing in epithelial lining fluid versus serum: an in vitro pharmacodynamic simulation.
Sevillano D; Alou L; Aguilar L; Echevarría O; Giménez MJ; Prieto J
J Antimicrob Chemother; 2006 Jun; 57(6):1128-33. PubMed ID: 16617063
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin.
Lucchi M; Damle B; Fang A; de Caprariis PJ; Mussi A; Sanchez SP; Pasqualetti G; Del Tacca M
J Antimicrob Chemother; 2008 Apr; 61(4):884-91. PubMed ID: 18252692
[TBL] [Abstract][Full Text] [Related]
18. Comparison of azithromycin and clarithromycin in their interactions with rifabutin in healthy volunteers.
Apseloff G; Foulds G; LaBoy-Goral L; Willavize S; Vincent J
J Clin Pharmacol; 1998 Sep; 38(9):830-5. PubMed ID: 9753212
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of clarithromycin in bronchial epithelial lining fluid.
Kikuchi E; Yamazaki K; Kikuchi J; Hasegawa N; Hashimoto S; Ishizaka A; Nishimura M
Respirology; 2008 Mar; 13(2):221-6. PubMed ID: 18339019
[TBL] [Abstract][Full Text] [Related]
20. Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study.
Schentag JJ; Klugman KP; Yu VL; Adelman MH; Wilton GJ; Chiou CC; Patel M; Lavin B; Paladino JA
Int J Antimicrob Agents; 2007 Sep; 30(3):264-9. PubMed ID: 17587549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
